scholarly journals Carbon nanotubes as a novel drug delivery system for anticancer therapy: a review

2013 ◽  
Vol 49 (4) ◽  
pp. 629-643 ◽  
Author(s):  
Swatantra Kumar Singh Kushwaha ◽  
Saurav Ghoshal ◽  
Awani Kumar Rai ◽  
Satyawan Singh

Carbon nanotubes (CNTs) were discovered in 1991 and shown to have certain unique physicochemical properties, attracting considerable interest in their application in various fields including drug delivery. The unique properties of CNTs such as ease of cellular uptake, high drug loading, thermal ablation, among others, render them useful for cancer therapy. Cancer is one of the most challenging diseases of modern times because its therapy involves distinguishing normal healthy cells from affected cells. Here, CNTs play a major role because phenomena such as EPR, allow CNTs to distinguish normal cells from affected ones, the Holy Grail in cancer therapy. Considerable work has been done on CNTs as drug delivery systems over the last two decades. However, concerns over certain issues such as biocompatibility and toxicity have been raised and warrant extensive research in this field.

2020 ◽  
pp. 29-36
Author(s):  
Sabita Shrestha

Carbon nanotubes are one-dimensional allotrope of carbon having high aspect ratio, high surface area, and excellent material properties. It has applications in many fields such as catalyst, nano-electronics, field emission, nano medicine, solar cells, energy storage etc. Drug delivery is one of the important applications of carbon nanotubes because of its unique properties such as high drug loading capacity, thermal ablation, ease of cellular uptake. This article briefly overviews the different steps in drug delivery and anticancer therapy such as mechanism of drug loading, transportation, distribution, metabolism and finally excretion of drug.


2015 ◽  
Vol 23 ◽  
pp. S247
Author(s):  
Mariangela Garofalo ◽  
Barbara Iovine ◽  
Lukasz Kuryk ◽  
Cristian Capasso ◽  
Mari Hirvinen ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (16) ◽  
pp. 12078-12086 ◽  
Author(s):  
Bharat Bhushan ◽  
Poornima Dubey ◽  
S. Uday Kumar ◽  
Abhay Sachdev ◽  
Ishita Matai ◽  
...  

In this work niclosamide was encapsulated into albumin nanoparticles through a desolvation method to improve its scope of application in cancer therapy.


2019 ◽  
Vol 9 (1) ◽  
pp. 30-45 ◽  
Author(s):  
K. Vohra ◽  
H. Dureja ◽  
V. Garg ◽  
R. Dutt

Background:Cancer has been considered as a deadly disease and its appropriate management is still a global challenge. The traditional anticancer therapeutics have been able to combat the disease to some extent but with numerous adverse effects which affect the quality of life of patients.Method:The introduction of alternative medicines, especially herbal medicines, has attracted the scientists’ due to low toxicity and high efficacy associated with them. However, their poor solubility and bioavailability decrease their efficacy. This has led to the increased use of targeted drug delivery systems in phyto-cancer therapy.Results:Nanoparticles (NPs), a novel drug delivery system has been widely used in the recent years due to their various advantages such as drug targeting, improved solubility, and bioavailability, high efficacy, low toxicity towards normal cells, low drug resistance, high drug loading at tumor site, etc.Conclusion:These benefits have also been observed in studies evaluating phytonanotherapy in cancer. The present review highlights current trends followed by phyto-cancer therapy using NPs. The recent studies conducted on herbal NPs for cancer therapy have also been enlisted.


2018 ◽  
Vol 6 (29) ◽  
pp. 4747-4755 ◽  
Author(s):  
Zhongjian Xie ◽  
Dou Wang ◽  
Taojian Fan ◽  
Chenyang Xing ◽  
Zhongjun Li ◽  
...  

Black phosphorus analogue tin sulfide nanosheets as photothermal and drug delivery agents with high drug loading capacity for cancer therapy.


NANO ◽  
2019 ◽  
Vol 14 (01) ◽  
pp. 1950013 ◽  
Author(s):  
Ying Jiang ◽  
Chaoyang Guan ◽  
Xu Liu ◽  
Yushan Wang ◽  
Huaqin Zuo ◽  
...  

Doxorubicin (DOX) plays an important part in lymphoma treatment. However, various side effects on normal tissues restrict its clinical use. Nanocarriers connected by Gly–Phe–Leu–Gly (GFLG) can be equipped with the advantages of nanoparticles (NPs), their enhanced permeability and retention (EPR) effect, and surface modifiability. Nanocarriers can also be specifically enzymatically hydrolyzed by cathepsin (Cath) B, a kind of enzyme highly expressed in tumor cells. In this work, we proposed a novel drug delivery system comprising GFLG conjugated with copper sulfide (CuS) NPs loaded with DOX. The system, designated as CuS-GFLG-DOX, could be used for NP-based targeted combination chemotherapy. Results showed that the drug delivery system had an appropriate diameter, good dispersibility, high encapsulation efficiency and high drug loading. The system also exhibited an excellent targeting of lymphoma cells and an enhanced antitumor activity. The possible pathway to induce cytotoxic effects was Bcl-2/caspase-mediated apoptosis pathway. In conclusion, CuS-GFLG-DOX could precisely deliver drugs to lymphoma cells and could be a novel and promising therapeutic option for lymphoma.


Sign in / Sign up

Export Citation Format

Share Document